Top 10 Key Players in the Philippines Marfan Syndrome Market | Top Companies & Insights 2026

Q: What role does government policy play for these companies in the Philippines?

Leading players align with Department of Health initiatives and the Rare Disease Act to ensure specialized treatments for Marfan syndrome are included in national health priorities.

Q: Which company leads in the Philippines Marfan Syndrome market?

Unilab is the leading brand for maintenance medications, while Novartis and AstraZeneca remain the key multinational players for innovative care.

Q: How are local manufacturers competing with global giants in the Philippines?

Local companies like Unilab and Pascual Lab maintain market share by offering high-quality, generic cardiovascular drugs at more accessible price points for long-term patient compliance.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA12166

Publication Date: Apr 2026

Top 10 Key Players in the Philippines Marfan Syndrome Market

Philippines Marfan Syndrome Market is influenced by global leaders in cardiovascular care, each competing for market share through cutting-edge therapies and treatments. Key players in the market include Novartis Philippines, AstraZeneca, and Sanofi.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Philippines Marfan Syndrome Market.

View Main Report Schedule Analyst Call

Philippines Marfan Syndrome Market Overview

According to 6Wresearch, The Philippines Marfan Syndrome Market is growing, owing to the rise in the incidence rate of cardiovascular complications associated with Marfan Syndrome. The Marfan Syndrome is a genetic disorder that causes abnormalities in the body's connective tissues, leading to dilation of the aortic root and other cardiovascular conditions.

The market is increasing due to the advancements in the treatments available for cardiovascular conditions, including beta blockers and angiotensin II receptor blockers, which are essential for Marfan Syndrome patients. In addition, the awareness about Marfan Syndrome, along with improvements in healthcare infrastructure is expected to boost the market.

Competitive Landscape

The competitive landscape of the Philippines Marfan Syndrome Industry comprises of global pharmaceutical companies and innovators of rare diseases. These companies are dedicated to enhance the health and wellbeing of patients suffering from Marfan Syndrome, by utilizing conventional and innovative drug delivery systems. Additionally, they engage in research and development to find solutions for the complex manifestations of Marfan Syndrome.

Below is a list of leading players operating in the Philippines Marfan Syndrome Market:

1. United Laboratories, Inc. (Unilab)

Company Name	United Laboratories, Inc. (Unilab)
Established Year	1945
Headquarters	Mandaluyong City, Philippines
Official Website	Click Here

Unilab is the dominant leader, known for its extensive range of affordable beta-blockers and high-quality cardiovascular maintenance medicines.

2. Pascual Laboratories, Inc.

Company Name	Pascual Laboratories, Inc.
Established Year	1946
Headquarters	Quezon City, Philippines
Official Website	Click Here

Pascual Lab maintains a strong presence through its portfolio of cardiovascular solutions and a commitment to accessible healthcare.

3. Natrapharm, Inc.

Company Name	Natrapharm, Inc.
Established Year	1988
Headquarters	Paranaque City, Philippines
Official Website	Click Here

This company focuses on metabolic and cardiovascular diseases, offering a wide range of specialized antihypertensive treatments used in Marfan syndrome.

4. Getz Pharma (Philippines), Inc.

Company Name	Getz Pharma (Philippines), Inc.
Established Year	2005 (Philippines Operations)
Headquarters	Makati City, Philippines
Official Website	Click Here

Getz Pharma is a leader in providing essential treatments for chronic conditions, particularly in the cardiovascular segments.

5. Euro-Med Laboratories Phil., Inc.

Company Name	Euro-Med Laboratories Phil., Inc.
Established Year	1988
Headquarters	Manila, Philippines
Official Website	-

Euro-Med provides essential pharmaceutical solutions and specialty products used in the clinical management of acute cardiovascular events.

6. Lloyd Laboratories, Inc.

Company Name	Lloyd Laboratories, Inc.
Established Year	1989
Headquarters	Bulacan, Philippines
Official Website	Click Here

Lloyd Laboratories is a key supplier of cardiovascular pharmaceuticals, known for its manufacturing excellence and supply of essential medicines.

7. Sanofi Philippines

Company Name	Sanofi Philippines
Established Year	1960
Headquarters	Makati City, Philippines (Regional HQ)
Official Website	Click Here

Sanofi is involved in providing innovative therapies and specialty medicines that target various risk factors associated with connective tissue disorders.

8. Novartis Healthcare Philippines, Inc.

Company Name	Novartis Healthcare Philippines, Inc.
Established Year	2001 (Consolidated)
Headquarters	Makati City, Philippines (Regional HQ)
Official Website	Click Here

Novartis contributes to the market with a focus on cutting-edge research in cardiovascular health and providing treatments that prevent disease progression.